4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-[2-(2-methyl-4-oxo-6,7,8,9-tetra­hydro-4H-pyrido[1,2-a]pyrimidin-3-yl)eth­yl]piperidinium nitrate

In the risperidone cation of the title compound, C(23)H(28)FN(4)O(2) (+)·NO(3) (−), the piperidine ring adopts a chair conformation and the tetra­hydro­pyridine ring is disordered over two orientations in a 0.620 (11):0.380 (11) ratio. N—H⋯O, C—H⋯O and C—H⋯F hydrogen bonds are present in the crystal...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yu, Zhang, Huai-Hong
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2969342/
https://www.ncbi.nlm.nih.gov/pubmed/21582911
http://dx.doi.org/10.1107/S1600536809022016
Descripción
Sumario:In the risperidone cation of the title compound, C(23)H(28)FN(4)O(2) (+)·NO(3) (−), the piperidine ring adopts a chair conformation and the tetra­hydro­pyridine ring is disordered over two orientations in a 0.620 (11):0.380 (11) ratio. N—H⋯O, C—H⋯O and C—H⋯F hydrogen bonds are present in the crystal structure.

Ejemplares similares